Citigroup’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Citigroup’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-400	Closed	-$9.05K	–	5752
2024 Q4	$9.05K	Hold	400	–	–	﹤0.01%	5399
2024 Q3	$9.85K	Hold	400	–	–	﹤0.01%	5286
2024 Q2	$9.25K	Hold	400	–	–	﹤0.01%	5162
2024 Q1	$9.63K	Hold	400	–	–	﹤0.01%	5213
2023 Q4	$9.2K	Hold	400	–	–	﹤0.01%	5210
2023 Q3	$8.14K	Hold	400	–	–	﹤0.01%	4594
2023 Q2	$9.34K	Hold	400	–	–	﹤0.01%	5085
2023 Q1	$9.31K	Hold	400	–	–	﹤0.01%	4761
2022 Q4	$10.1K	Hold	400	–	–	﹤0.01%	4837
2022 Q3	$11K	Hold	400	–	–	﹤0.01%	4953
2022 Q2	$12K	Hold	400	–	–	﹤0.01%	5269
2022 Q1	$14K	Hold	400	–	–	﹤0.01%	5356
2021 Q4	$18K	Hold	400	–	–	﹤0.01%	5414
2021 Q3	$20K	Hold	400	–	–	﹤0.01%	5236
2021 Q2	$21K	Hold	400	–	–	﹤0.01%	5271
2021 Q1	$18K	Buy	+400	New	+$19.5K	﹤0.01%	5317

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

CCA

Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return

Citigroup's IDNA Position: Q1 2025 in Review

Citigroup sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2025, closing a stake of 400 shares — an estimated $9.05K sold.

Citigroup first reported a position in IDNA in Q1 2021 and held it in 16 quarters. The position peaked at $21K in Q2 2021. 48 funds tracked by Wall St. Rank hold IDNA as of Q1 2025.

Citigroup reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2025 after selling out during the quarter.
Citigroup sold 400 iShares Genomics Immunology and Healthcare ETF shares in Q1 2025, an estimated $9.05K.
Citigroup first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and held it in 16 quarters.
Citigroup's iShares Genomics Immunology and Healthcare ETF position peaked at $21K in Q2 2021.
48 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.